This inventor holds 1 USPTO granted patent. Top assignee: Novarx Corporation. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Dorigo Oliver: Innovator in Cancer Immunotherapy
Introduction
Dorigo Oliver is a prominent inventor based in San Diego, CA, who has made significant contributions to the field of cancer immunotherapy. His innovative approach focuses on enhancing the immune response against tumors, providing new avenues for cancer treatment. With a strong commitment to improving patient outcomes, Oliver's work is paving the way for advancements in cancer therapies.
Latest Patents
Dorigo Oliver holds a patent titled "Compositions and methods for enhanced tumor cell immunity in vivo." This invention outlines a method for preventing or reducing the severity of cancer in a subject by stimulating the immune response against the cancer. The method involves administering tumor cells that are genetically modified to inhibit the expression of immunosuppressive agents. This innovative approach aims to bolster the subject's immune system, offering a promising strategy for cancer treatment. Oliver's patent is a testament to his dedication to advancing medical science and improving therapeutic options for patients.
Career Highlights
Oliver is currently associated with Novarx Corporation, where he continues to develop groundbreaking solutions in cancer treatment. His work at Novarx Corporation reflects his commitment to translating scientific research into practical applications that can benefit patients. With a focus on innovative therapies, Oliver is at the forefront of cancer research and development.
Collaborations
Throughout his career, Dorigo Oliver has collaborated with esteemed colleagues, including Fakhrai Habib and Sobol E Robert. These collaborations have fostered a dynamic exchange of ideas and expertise, further enhancing the impact of their collective work in the field of cancer immunotherapy.
Conclusion
Dorigo Oliver's contributions to cancer immunotherapy exemplify the power of innovation in addressing complex medical challenges. His patented methods and ongoing work at Novarx Corporation highlight his dedication to improving cancer treatment and patient care. Oliver's efforts are a significant step forward in the fight against cancer, showcasing the potential of enhanced immune responses in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile